Literature DB >> 23695838

Critical considerations on the combined use of ¹⁸F-FDG and ¹⁸F-fluoride for PET assessment of metastatic bone disease.

Gang Cheng, Thomas C Kwee, Sandip Basu, Abass Alavi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23695838     DOI： 10.1007/s00259-013-2459-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  43 in total

1.  Defining co-related parameters between 'metabolic' flare and 'clinical', 'biochemical', and 'osteoblastic' flare and establishing guidelines for assessing response to treatment in cancer.

Authors:  Sandip Basu; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-04       Impact factor: 9.236

Review 2.  Diagnosis of bone metastases: a meta-analysis comparing ¹⁸FDG PET, CT, MRI and bone scintigraphy.

Authors:  Hui-Lin Yang; Tao Liu; Xi-Ming Wang; Yong Xu; Sheng-Ming Deng
Journal:  Eur Radiol       Date:  2011-09-02       Impact factor: 5.315

3.  The diagnostic and prognostic effectiveness of F-18 sodium fluoride PET-CT in detecting bone metastases for hepatocellular carcinoma patients.

Authors:  Ruoh-Fang Yen; Chih-Yu Chen; Mei-Fang Cheng; Yen-Wen Wu; Yu-Chien Shiau; Karl Wu; Ruey-Long Hong; Chong-Jen Yu; Kao-Lun Wang; Rong-Sen Yang
Journal:  Nucl Med Commun       Date:  2010-07       Impact factor: 1.690

Review 4.  FDG PET and PET/CT in the Management of Pediatric Lymphoma Patients.

Authors:  Gang Cheng; Sabah Servaes; Abass Alavi; Hongming Zhuang
Journal:  PET Clin       Date:  2009-07-25

5.  Increased 18F-FDG uptake in degenerative disease of the spine: Characterization with 18F-FDG PET/CT.

Authors:  Ron S Rosen; Laura Fayad; Richard L Wahl
Journal:  J Nucl Med       Date:  2006-08       Impact factor: 10.057

Review 6.  A new dimension of FDG-PET interpretation: assessment of tumor biology.

Authors:  Thomas C Kwee; Sandip Basu; Babak Saboury; Valentina Ambrosini; Drew A Torigian; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-01-12       Impact factor: 9.236

7.  Biopsy versus FDG PET/CT in the initial evaluation of bone marrow involvement in pediatric lymphoma patients.

Authors:  Gang Cheng; Wengen Chen; Wichana Chamroonrat; Drew A Torigian; Hongming Zhuang; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-20       Impact factor: 9.236

Review 8.  Meta-analysis: comparison of F-18 fluorodeoxyglucose-positron emission tomography and bone scintigraphy in the detection of bone metastasis in patients with lung cancer.

Authors:  Ming-Che Chang; Jin-Hua Chen; Ji-An Liang; Cheng-Chieh Lin; Kuang-Tao Yang; Kai-Yuan Cheng; Jun-Jun Yeh; Chia-Hung Kao
Journal:  Acad Radiol       Date:  2011-12-14       Impact factor: 3.173

9.  Analysis of 18F-FDG PET diffuse bone marrow uptake and splenic uptake in staging of Hodgkin's lymphoma: a reflection of disease infiltration or just inflammation?

Authors:  Pierre Y Salaun; Thomas Gastinne; Caroline Bodet-Milin; Loïc Campion; Pierre Cambefort; Anne Moreau; Steven Le Gouill; Christian Berthou; Philippe Moreau; Françoise Kraeber-Bodéré
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-06-05       Impact factor: 9.236

10.  Comparison of whole-body FDG-PET to bone scan for detection of bone metastases in patients with a new diagnosis of lung cancer.

Authors:  Sendhil Kumar Cheran; James E Herndon; Edward F Patz
Journal:  Lung Cancer       Date:  2004-06       Impact factor: 5.705
View more
  4 in total

1.  Combined 18F-fluoride and 18F-FDG PET/CT: a response based on actual data from prospective studies.

Authors:  Andrei Iagaru; Camila Mosci; David W Dick; Mike Sathekge; Paula Lapa; Joao M de Lima; Sanjiv Sam Gambhir
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-21       Impact factor: 9.236

2.  Optimizing an 18F-NaF and 18F-FDG cocktail for PET assessment of metastatic castration-resistant prostate cancer.

Authors:  Urban Simoncic; Scott Perlman; Glenn Liu; Robert Jeraj
Journal:  Nucl Med Commun       Date:  2015-12       Impact factor: 1.690

3.  Combined Injection of (18)F-Fluorodeoxyglucose and 3'-Deoxy-3'-[(18)F]fluorothymidine PET Achieves More Complete Identification of Viable Lung Cancer Cells in Mice and Patients than Individual Radiopharmaceutical: A Proof-of-Concept Study.

Authors:  Xiao-Feng Li; Tao Huang; Huijie Jiang; Xuemei Wang; Baozhong Shen; Xiangcheng Wang; Chin K Ng; Gregory C Postel; A Cahid Civelek
Journal:  Transl Oncol       Date:  2013-12-01       Impact factor: 4.243

4.  Cancer metastasizes to the bone marrow and not to the bone: time for a paradigm shift!

Authors:  Poul Flemming Høilund-Carlsen; Søren Hess; Thomas J Werner; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-06       Impact factor: 9.236
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.